CureVac
ID: 4069183A biopharmaceutical company developing prophylactic and therapeutic application of messenger RNA, which can be used to develop vaccines. It was founded in 2000 and is located in Tübingen, Germany.
9
Funding Rounds
$1.8b
Money raised
Recent Funding Rounds
Overview
A biopharmaceutical company developing prophylactic and therapeutic application of messenger RNA, which can be used to develop vaccines. It was founded in 2000 and is located in Tübingen, Germany.
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| In**** Ho*** | - | - | linkedin twitter |
| Fl***** vo* de* M�**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| In**** Ho*** | - | - | linkedin twitter |
Funding
Funding series
Funding Series Analysis
The company CureVac has raised a total of $1.15b in funding over 9 rounds.
Key Insights:
- CureVac Venture round, February 2, 2021: $450m
- CureVac Grant (money), September 15, 2020: $306m
- CureVac Series F round, November 3, 2015: $119.63m
- CureVac Series F round, November 2015: $29.5m
- CureVac Series E round, March 5, 2015: $76m
- CureVac Series D round: $104.43m
- CureVac funding round, May 10, 2010: $35.25m
- CureVac Series B round: $26.68m
- CureVac Private Funding round, July 21, 2020: $640m
CureVac Series D round
$104.43m
CureVac Series B round
$26.68m
Industries
CureVac is active in the following industries: